☆ 4.7 Article

Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study

JOURNAL OF CLINICAL MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Letter Dermatology

Real-world data on the clinical use of secukinumab in pediatric generalized pustular psoriasis: A 48-week retrospective study

Shi-Fan Ruan et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)

添加到收藏夹

Letter Dermatology

Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting

Alejandra Reolid et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

添加到收藏夹

Letter Dermatology

Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis

G. Avallone et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

添加到收藏夹

Letter Dermatology

Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab

G. Pavia et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

添加到收藏夹

Article Dermatology

A Case of Recalcitrant Circinate Generalized (Lapiere) Psoriasis Successfully Treated with Risankizumab

Angelo Ruggiero et al.

Summary: Circinate psoriasis is a rare subtype of generalized subacute pustular psoriasis characterized by annular circinate lesions with micro-pustules at the borders. It can have a negative impact on patients' quality of life. Although various systemic treatments have been reported, data on biologics for this subtype are lacking. We present a case of circinate psoriasis unresponsive to conventional and most biologic therapies but successfully treated with risankizumab.

CASE REPORTS IN DERMATOLOGY (2022)

添加到收藏夹

Letter Dermatology

Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice?

Luca Mastorino et al.

DERMATOLOGIC THERAPY (2022)

添加到收藏夹

Letter Dermatology

Effectiveness and safety profile of secukinumab for the treatment of patients with generalized pustular psoriasis in daily practice

A. Reymundo et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Trial of Spesolimab for Generalized Pustular Psoriasis

H. Bachelez et al.

Summary: In a phase 2 randomized trial, spesolimab, an interleukin-36 receptor inhibitor, showed a higher rate of lesion clearance in GPP patients compared to placebo, but was associated with risks of infections and systemic drug reactions. Further longer and larger trials are needed to assess the efficacy and safety of spesolimab in patients with pustular psoriasis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Dermatology

Generalized pustular psoriasis-Dawn of a new era in targeted immunotherapy

Ruth Neuhauser et al.

EXPERIMENTAL DERMATOLOGY (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis

Amit Khatri et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2019)

添加到收藏夹

Article Dermatology

Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study

Shigetoshi Sano et al.

JOURNAL OF DERMATOLOGY (2018)

添加到收藏夹

Article Dermatology

Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J)

Hidehisa Saeki et al.

JOURNAL OF DERMATOLOGY (2017)

添加到收藏夹

Article Dermatology

Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway

Robert Bissonnette et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2017)

添加到收藏夹

Review Dermatology

European consensus statement on phenotypes of pustular psoriasis

A. A. Navarini et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.